Development and maintenance of a multigenotypic aged mouse colony
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N95022D00018
- Awardee
-
Charles River Laboratories, Inc. UEI NAPSK1UAMAE5
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Task orders
- 5 $25,189,751 obligated
Award facts
- Opportunity
-
- Development and Maintenance of a Multigenotypic Aged Mouse Colony Pre-Solicitation · 75N95021R00051 · Posted Jul 21, 2021
- Combined order value
- $25,189,751 Current and potential, with all options
- Last date to order 41% complete
- IDV ceiling 39% used
- $65,104,416.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 112990 All Other Animal Production
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute on Aging awarded an indefinite-delivery contract to Charles River Laboratories, Inc. with a ceiling of $65.1 million on September 30, 2022, for development and maintenance of a multigenotypic aged mouse colony. This is a multiple-award vehicle with no set-aside designation.
Place of performance is Wilmington, Massachusetts. The solicitation sought capability to house, breed, monitor, and ship over 100,000 mice annually within controlled barrier environments for aging research, with colony population ranging from 17,000 mice in year one to 105,000 mice annually for years four through seven across a ten-year initial award period.
The contract ceiling is $65.1 million; the period of performance runs through September 29, 2032. NAICS code 541711 (Research and Development in Biotechnology) and PSC code V2YR (Live Animals, Not Raised for Food) apply.
Task orders issued under this IDIQ total $16.9 million to date. A cost-plus-fixed-fee delivery order for $7.2 million was awarded September 30, 2025, with completion September 29, 2026. A prior delivery order for $6.7 million was awarded September 30, 2024, with completion September 29, 2025. Earlier orders include a $2.3 million delivery order (awarded September 30, 2023, through September 29, 2024) and a $736,375 delivery order (awarded September 30, 2022, through September 29, 2023). All task orders are performed in Wilmington, Massachusetts under cost-plus-fixed-fee pricing.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N95022D00018?
75N95022D00018 was awarded to Charles River Laboratories, Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 30, 2022.
How much is contract 75N95022D00018 worth?
Orders under 75N95022D00018 have obligated $25,189,751. 75N95022D00018's own ceiling is $65,104,416.
How many orders have been placed under contract 75N95022D00018?
5 orders have been placed under 75N95022D00018, the latest on September 30, 2026.
Who can order from contract 75N95022D00018?
75N95022D00018 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N95022D00018 competed?
The extent of competition for 75N95022D00018 was full and open competition. The government received 2 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV